Clincosm LogoSign in Get a demo

Type 2 Diabetes

Showing NaN - NaN of 80
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes Trial in Worldwide (Dulaglutide, Placebo)

Completed
Has Results
  • Type 2 Diabetes
  • Glendale, California
  • +65 more
Sep 5, 2019

Type 2 Diabetes, Chronic Kidney Disease Trial in Worldwide (Dulaglutide, Insulin glargine, Insulin lispro)

Completed
Has Results
  • Type 2 Diabetes
  • Chronic Kidney Disease
  • Montgomery, Alabama
  • +88 more
Sep 6, 2019

Type 2 Diabetes Trial in United States (LY2189102, Placebo)

Completed
Has Results
  • Type 2 Diabetes
  • Mobile, Alabama
  • +17 more
Sep 6, 2019

Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)

Completed
Has Results
  • Cardiovascular Disease
  • +4 more
  • Lorcaserin hydrochloride
  • Placebo
  • Alexander City, Alabama
  • +498 more
Jun 27, 2019

Type 2 Diabetes Trial in United States (Salsalate, Placebo)

Completed
Has Results
  • Type 2 Diabetes
  • New Haven, Connecticut
  • +15 more
Mar 25, 2019

Diabetes and Gastric By- Pass

Completed
Has Results
  • Type 2 Diabetes
    • Dallas, Texas
      Clinical and Translational Research Center
    Mar 12, 2019

    Type 2 Diabetes Trial in United States (ITCA 650 (exenatide in DUROS))

    Terminated
    • Type 2 Diabetes
    • ITCA 650 (exenatide in DUROS)
    • Birmingham, Alabama
    • +50 more
    Mar 4, 2019

    Type 2 Diabetes Trial in Dallas (Levemir (Detemir) and Novolog (Aspart) Insulin)

    Withdrawn
    • Type 2 Diabetes
    • Levemir (Detemir) and Novolog (Aspart) Insulin
    • Dallas, Texas
      Parkland Memorial Hospital
    Jan 15, 2019

    Type 2 Diabetes Trial in Worldwide (Saxagliptin, Dapagliflozin, Sitagliptin)

    Completed
    Has Results
    • Type 2 Diabetes
    • Mesa, Arizona
    • +78 more
    May 29, 2018

    Type 2 Diabetes Trial in Puerto Rico, United States (INCB013739, Placebo comparator matching INCB013739, Metformin)

    Completed
    • Type 2 Diabetes
    • Birmingham, Alabama
    • +67 more
    Feb 12, 2018

    Role of Pancreatic Triglyceride Content in Beta-cell Function

    Completed
    Has Results
    • Obesity
    • Type 2 Diabetes
    • No intervention planned.
    • Dallas, Texas
      UT Southwestern Medical Center
    Nov 29, 2017

    Changes in Ectopic Fat Following Surgically Induced Weight Loss

    Completed
    Has Results
    • Obesity
    • Type 2 Diabetes
      • Dallas, Texas
        University of Texas Southwestern
      Nov 17, 2017

      Obesity, Type 2 Diabetes Trial in Dallas (pioglitazone, )

      Completed
      Has Results
      • Obesity
      • Type 2 Diabetes
      • Dallas, Texas
        UT Southwestern Medical Center
      Nov 14, 2017

      Type 2 Diabetes Trial in Worldwide (Saxagliptin, Metformin XR, Dapagliflozin)

      Completed
      Has Results
      • Type 2 Diabetes
      • Birmingham, Alabama
      • +138 more
      Mar 29, 2017

      Type 2 Diabetes Trial in Canada, United States (Dapagliflozin, Placebo)

      Completed
      Has Results
      • Type 2 Diabetes
      • Jonesboro, Arkansas
      • +22 more
      Mar 31, 2017

      Type 2 Diabetes Trial in Worldwide (Insulin glargine/lixisenatide (HOE901/AVE0010), Insulin glargine (HOE901), Metformin

      Completed
      Has Results
      • Type 2 Diabetes
      • Insulin glargine/lixisenatide (HOE901/AVE0010)
      • +2 more
      • Birmingham, Alabama
      • +235 more
      Mar 31, 2017

      Type 2 Diabetes Trial in Worldwide (Insulin glargine/lixisenatide Fixed Ratio Combination, Insulin glargine (HOE901),

      Completed
      Has Results
      • Type 2 Diabetes
      • Insulin glargine/lixisenatide Fixed Ratio Combination
      • +3 more
      • Phoenix, Arizona
      • +272 more
      Mar 31, 2017

      Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Placebo matching Dapagliflozin, Thiazolidinedione (Pioglitazone))

      Completed
      Has Results
      • Type 2 Diabetes
      • Anniston, Alabama
      • +88 more
      Jan 3, 2017

      Type 2 Diabetes, Obesity Trial in United States (EndoBarrier, Sham Procedure)

      Terminated
      Has Results
      • Type 2 Diabetes
      • Obesity
      • EndoBarrier
      • Sham Procedure
      • Birmingham, Alabama
      • +24 more
      Dec 2, 2016

      Type 2 Diabetes Trial in Worldwide (ITCA 650, ITCA )

      Completed
      • Type 2 Diabetes
      • ITCA 650
      • ITCA placebo
      • Chandler, Arizona
      • +41 more
      Jan 26, 2017

      Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Placebo-matching dapagliflozin)

      Completed
      Has Results
      • Type 2 Diabetes
      • Birmingham, Alabama
      • +328 more
      Dec 2, 2016

      Type 2 Diabetes Trial in Worldwide (Lixisenatide (AVE0010), Insulin glulisine QD, Insulin glulisine TID)

      Completed
      Has Results
      • Type 2 Diabetes
      • Lixisenatide (AVE0010)
      • +4 more
      • Sun City, Arizona
      • +198 more
      Nov 4, 2016

      Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Placebo matching Dapagliflozin)

      Completed
      Has Results
      • Type 2 Diabetes
      • Birmingham, Alabama
      • +297 more
      Nov 10, 2016

      Type 2 Diabetes Trial in Worldwide (, exenatide)

      Completed
      Has Results
      • Type 2 Diabetes
      • Peoria, Arizona
      • +58 more
      Oct 21, 2016

      Type 2 Diabetes, Hyperlipidemia Trial in United States (Colesevelam HCl, rosiglitazone maleate, sitagliptin phosphate)

      Completed
      Has Results
      • Type 2 Diabetes
      • Hyperlipidemia
      • Colesevelam HCl
      • +2 more
      • La Mesa, California
      • +19 more
      Aug 23, 2016